Efektivitas Progesteron Dalam Mengembalikan Siklus Menstruasi Pada Penderita Polycystic Ovary Syndrome (Pcos) Serta Tinjauannya Dalam Pandangan Islam

  • Latifah Ratna Dewi Universitas YARSI
  • Fita Maulina Universitas YARSI
  • M. Arsyad Universitas YARSI
  • Siti Maulidya Sari Universitas YARSI
  • Muh. Fazlurrahman Anshar Universitas YARSI
Keywords: Progesterone, PCOS, Menstrual Cycle, Effectiveness, Islamic Perspective

Abstract

Polycystic ovary syndrome (PCOS) can cause menstrual cycle disorders such as oligomenorrhea or amenorrhea, which can be treated with progesterone therapy. The choice of progesterone therapy depends on the patient's clinical condition, the effectiveness of the therapy, and potential side effects. This study aims to assess the effectiveness of progesterone in restoring menstrual cycles in PCOS sufferers. The research method was conducted through a survey using a Google Form distributed to members of the Indonesian PCOS Fighter community. Data included menstrual cycle changes, the type of progesterone used, dosage, duration of consumption, and factors influencing therapy effectiveness. Descriptive and bivariate analyses were used to assess the relationship between variables. The results showed that micronized progesterone was the most commonly used type, but the type of progesterone did not significantly affect therapy effectiveness.  Most respondents required 4-6 months for menstrual cycle regularity, and progesterone dosage was not significantly associated with therapy effectiveness. Exercise and a high-protein, low-sugar diet were significantly associated with menstrual cycle regularity, while vitamin D consumption and a history of diabetes or obesity were not significantly associated. The study concluded that the effectiveness of progesterone therapy is more influenced by the patient's metabolic condition, endometrial response, and lifestyle quality. The use of progesterone hormone therapy is considered permissible in Islam as an effort to maintain women's health and fertility.

Downloads

Download data is not yet available.

References

Ariani, N.K.S., Susanti, N.L.P.D., Parwati, N.W.M. & Haryati, N.P.S. (2022) ‘The Influence of Video-Based Health Education in Modifying Early Screening Efforts for Polycystic Ovary Syndrome (PCOS)’, Asian Journal of Health Research, 1(3), pp. 24–30. doi:10.55561/ajhr.v1i3.54.
Baracat, M.C.P. et al. (2023) ‘Hormonal and Metabolic Factors Influence the Action of Progesterone on the Endometrium of Women with Polycystic Ovary Syndrome’, Diagnostics, 13(3), p. 382. doi:10.3390/diagnostics13030382.
Bode, D., Seehusen, D.A. & Baird, D. (2012) ‘Hirsutism in Women’, American Family Physician, 85(4), pp. 373–380.
Budiyanto & Akbar, D.L. (2020) ‘Konsep Kesehatan dalam Al-Qur’an dan Hadis’, Al-Bayan: Jurnal Ilmu Al-Qur’an dan Hadist, 3(2), pp. 157–164. doi:10.35132/albayan.v3i1.83.
Cable, J.K. & Grider, M.H. (2023) Physiology, Progesterone. StatPearls Publishing. Available at: https://www.ncbi.nlm.nih.gov/books/NBK558960/ (Accessed: 5 November 2025).
Chen, W. & Pang, Y. (2021) ‘Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites’, Metabolites, 11(12), p. 869. doi:10.3390/metabo11120869.
Christ, J.P. & Cedars, M.I. (2023) ‘Current Guidelines for Diagnosing PCOS’, Diagnostics, 13(6), p. 1113. doi:10.3390/diagnostics13061113.
Coumba Aicha Thiam, Lilac, M. & Antoine-Frank, C.D. (2021) ‘Polycystic ovarian syndrome: pathogenesis and management’, International Journal of Reproduction, Contraception, Obstetrics and Gynecology, 10(2), pp. 803–803. doi:10.18203/2320-1770.ijrcog20210350.
Dewi, R. (2024) ‘Konsep Kesehatan Reproduksi Perempuan dalam al-Qur’an’, Mawaizh: Jurnal Dakwah dan Pengembangan Sosial Kemanusiaan, 10(2). Available at: https://jurnal.lp2msasbabel.ac.id/maw/article/view/920(Accessed: 5 November 2025).
Diamanti-Kandarakis, E. (2006) ‘Insulin resistance in PCOS: pathophysiology and clinical implications’, Endocrine Reviews, 27(3), pp. 284–306.
Endocrine Society (2013) ‘Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline’, Journal of Clinical Endocrinology & Metabolism, 98(12), pp. 4565–4592.
ESHRE (2018) International evidence-based guideline for the assessment and management of polycystic ovary syndrome. European Society of Human Reproduction and Embryology.
Fahmy, M.W., Sanganeria, T. & Munakomi, S. (2022) ‘Anatomy, Abdomen and Pelvis: Superficial Perineal Space’. Available at: https://www.ncbi.nlm.nih.gov/books/NBK542289/ (Accessed: 13 December 2024).
Ghummiah, S.M. & Mualifah, L. (2024) ‘Islam dan Isu Gender: Kesehatan Reproduksi Perempuan dalam Relasi Pernikahan’, Syakhshiyyah: Jurnal Hukum Keluarga Islam, 4(1). Available at: https://e-journal.metrouniv.ac.id/syakhsiyah/id/article/view/9251 (Accessed: 5 November 2025).
Gulam Saidunnisa Begum et al. (2024) ‘Prevalence of Polycystic Ovary Syndrome (PCOS) and Its Associated Risk Factors among Medical Students in Two Countries’, International Journal of Environmental Research and Public Health, 21(9), p. 1165. doi:10.3390/ijerph21091165.
Hardi Cahyo Utomo, Haviz Yuad & Burhan, I.R. (2024) ‘The Relationship of Vitamin D to Polycystic Ovary Syndrome (PCOS) Teenagers’, Andalas Obstetrics and Gynecology Journal, 8(1), pp. 615–631. doi:10.25077/aoj.8.1.615-631.2024.
Himpunan Endokrinologi Reproduksi dan Fertilitas Indonesia (HIFERI) & POGI (2016) Konsensus Tata Laksana Sindrom Ovarium Polikistik (SOPK). Available at: https://www.pogi.or.id/wp-content/uploads/download-manager-files/KONSENSUS%20SOPK.pdf
Holick, M.F., Chen, T.C., Lu, Z. & Sauter, E. (2011) ‘Vitamin D and skin physiology: role in health and disease’, Physiological Reviews, 91(1), pp. 1–33.
Katzung, B.G. (2018) Basic & Clinical Pharmacology. 14th edn. New York: McGraw-Hill Education.
Lagowska, E., Malinowska, A. & Cieszczyk, P. (2018) ‘Vitamin D supplementation and menstrual cycle regularity in young women with PCOS’, Nutrients, 10(11), p. 1634.
Lentscher, J.A. & DeCherney, A. (2020) ‘Clinical Presentation and Diagnosis of Polycystic Ovarian Syndrome’, Clinical Obstetrics & Gynecology, 64(1). doi:10.1097/grf.0000000000000563.
Liu, J. et al. (2021) ‘Measuring the global disease burden of polycystic ovary syndrome in 194 countries: Global Burden of Disease Study 2017’, Human Reproduction, 36(4), pp. 1108–1119. doi:10.1093/humrep/deaa371.
Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L. & Azziz, R. (2016) ‘Criteria, prevalence, and phenotypes of polycystic ovary syndrome’, Fertility and Sterility, 106(1), pp. 6–15.
MacLean, J.A. & Hayashi, K. (2022) ‘Progesterone Actions and Resistance in Gynecological Disorders’, Cells, 11(4), p. 647. doi:10.3390/cells11040647.
Marquardt, R.M. et al. (2019) ‘Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?’, International Journal of Molecular Sciences, 20(15), p. 3822.
Mescher, A.L. (2023) Junqueira’s Basic Histology: Text and Atlas. 17th edn. McGraw Hill Professional.
Moridi, M. et al. (2021) ‘The effect of vitamin D supplementation on menstrual cycle, hormones, and metabolic markers in PCOS’, Reproductive Biology and Endocrinology, 19(1), p. 65.
Nagy, B. et al. (2021) ‘Key to Life: Physiological Role and Clinical Implications of Progesterone’, International Journal of Molecular Sciences, 22(20), p. 11039.
Rasquin, L. & Mayrin, J.V. (2022) Polycystic Ovarian Disease. Available at: https://www.ncbi.nlm.nih.gov/books/NBK459251/.
Salari, N. et al. (2024) ‘Global prevalence of polycystic ovary syndrome in women worldwide’, Archives of Gynecology and Obstetrics. doi:10.1007/s00404-024-07607-x.
Sari, D.A., Kurniawati, E.Y. & Ashari, M.A. (2023) ‘Skrining dan Determinan Kejadian Sindrom Ovarium Polikistik pada Remaja’, Jurnal Ilmu Kebidanan, 9(2), pp. 102–106.
Saribanon, N. et al. (2016) Haid dan Kesehatan Menurut Ajaran Islam. Jakarta: MUI & Universitas Nasional.
Siddiqui, S. et al. (2022) ‘A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome’, Journal of Assisted Reproduction and Genetics, 39(11). doi:10.1007/s10815-022-02625-7.
Sundström-Poromaa, I. et al. (2020) ‘Progesterone – Friend or foe?’, Frontiers in Neuroendocrinology, 59, p. 100856.
Thiyagarajan, D.K., Basit, H. & Jeanmonod, R. (2022) Physiology, Menstrual Cycle. Available at: https://www.ncbi.nlm.nih.gov/books/NBK500020/.
Wahid, S., Rahman, N., Hassan, M. & Yusuf, M. (2024) ‘Effect of regular physical activity on insulin sensitivity, androgen levels, and ovulatory function in women with PCOS’, Journal of Reproductive Endocrinology, 12(1), pp. 45–53.
World Health Organization (2023) Polycystic Ovary Syndrome. Available at: https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome.
World Health Organization (2025) Polycystic Ovary Syndrome. Available at: https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome.
Zhao, L., Cheng, X. & Huang, Y. (2024) ‘High-protein dietary intervention improves insulin resistance and androgen excess in women with PCOS’, Nutrition & Metabolism, 21(1), p. 17.
Published
2026-01-31